BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2377170)

  • 21. High-frequency jet ventilation in the early management of respiratory distress syndrome is associated with a greater risk for adverse outcomes.
    Wiswell TE; Graziani LJ; Kornhauser MS; Cullen J; Merton DA; McKee L; Spitzer AR
    Pediatrics; 1996 Dec; 98(6 Pt 1):1035-43. PubMed ID: 8951251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era.
    Wright K
    J Assoc Acad Minor Phys; 1999; 10(4):82-7. PubMed ID: 10826014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with survanta, a modified bovine surfactant.
    Whitsett JA; Hull WM; Luse S
    Pediatrics; 1991 Apr; 87(4):505-10. PubMed ID: 2011428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single versus repetitive doses of natural surfactant as treatment of respiratory distress syndrome in premature lambs.
    Walther FJ; Blanco CE; Houdijk M; Bevers EM
    Pediatr Res; 1985 Feb; 19(2):224-7. PubMed ID: 3920637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose versus low-dose bovine surfactant treatment in very premature infants.
    Gortner L; Pohlandt F; Bartmann P; Bernsau U; Porz F; Hellwege HH; Seitz RC; Hieronimi G; Kuhls E; Jorch G
    Acta Paediatr; 1994 Feb; 83(2):135-41. PubMed ID: 8193488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g].
    Speer CP; Harms K; Herting E; Müller F; Schröter W; Teichmann AT; Neumann N; Curstedt T; Robertson B
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):359-64. PubMed ID: 2197165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How best to administer surfactant to VLBW infants?
    Kribs A
    Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F238-40. PubMed ID: 21444298
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of severe respiratory distress syndrome in the premature infant with natural surfactant].
    Speer CP; Harms K; Müller U; Schröter W; Curstedt T; Robertson B
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):65-70. PubMed ID: 3130571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxygen requirement and surfactant therapy in preterm infants after delivery.
    Toriyama M; Ishiguro A; Motojima Y; Yamana K; Sobajima H; Tamura M
    Pediatr Int; 2015; 57(1):55-9. PubMed ID: 24980721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful surfactant replacement therapy in two infants with ARDS due to chlamydial pneumonia.
    Harms K; Herting E
    Respiration; 1994; 61(6):348-52. PubMed ID: 7824816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early versus late surfactant replacement therapy in severe respiratory distress syndrome.
    Speer CP; Harms K; Herting E; Neumann N; Curstedt T; Robertson B
    Lung; 1990; 168 Suppl():870-6. PubMed ID: 2117206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome.
    Dinger J; Schwarze R; Rupprecht E
    Pediatr Radiol; 1997 Jan; 27(1):26-31. PubMed ID: 8995163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RETREATMENT WITH SURFACTANT IN VERY LOW BIRTH WEIGHT PRETERM INFANTS: RISK PREDICTORS AND THEIR INFLUENCE ON NEONATAL OUTCOMES.
    Ferri WAG; Silva ACD; Sacramento EMF; Calixto C; Aragon DC; Caldas JPS
    Rev Paul Pediatr; 2020; 39():e2019360. PubMed ID: 33206840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of bovine surfactant in premature lambs after intra-tracheal application.
    Gortner L; Pohlandt F; Disse B; Weller E
    Eur J Pediatr; 1990 Jan; 149(4):280-3. PubMed ID: 2303078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in the care of very low birth-weight infants].
    Nakamura H
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Feb; 40(2):231-7. PubMed ID: 3283271
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of surfactant replacement therapy on cerebral and systemic circulation and lung function.
    Schipper JA; Mohammad GI; van Straaten HL; Koppe JG
    Eur J Pediatr; 1997 Mar; 156(3):224-7. PubMed ID: 9083765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The newborn infant weighing less than 1,000 g at the Feldkirch district hospital].
    Schurz AR; Müller G; Tscharre A
    Gynakol Rundsch; 1990; 30 Suppl 1():18-20. PubMed ID: 2079261
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute and protracted effects of intratracheal surfactant application on internal carotid blood flow velocity, blood pressure and carbondioxide tension in very low birth weight infants.
    Jorch G; Rabe H; Garbe M; Michel E; Gortner L
    Eur J Pediatr; 1989 Aug; 148(8):770-3. PubMed ID: 2507321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infants.
    Facco M; Nespeca M; Simonato M; Isak I; Verlato G; Ciambra G; Giorgetti C; Carnielli VP; Cogo PE
    PLoS One; 2014; 9(12):e93612. PubMed ID: 25551219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study.
    Victorin LH; Deverajan LV; Curstedt T; Robertson B
    Biol Neonate; 1990; 58(3):121-6. PubMed ID: 2279046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.